OCCR Signs Cooperation Agreement with Indonesia’s Leading Medical Enterprise
- On 2026-07-07 10:14:18
- By OCCR
PT Ocean Purification Indonesia (OCCR), the Indonesian subsidiary of OCEAN Purification Group, has formally entered into a long-term strategic cooperation agreement with Indonesia’s top domestic medical enterprise. Senior management teams from both parties attended the official signing ceremony after rounds of in-depth business negotiations, marking a brand-new milestone for medical and biopharmaceutical cleanroom construction across Southeast Asia.

The strategic partnership centers on full-range medical and biopharmaceutical cleanroom decoration solutions, including integrated design, construction and maintenance for hospital operating rooms, sterile wards, clinical laboratories, medical-grade dust-free workshops, as well as biopharmaceutical production workshops, cell culture labs, sterile API packaging workshops and pharmaceutical QC clean testing areas. Drawing on OCCR’s years of regional expertise in purification engineering, combined with our partner’s extensive local medical resources, hospital operation and biopharmaceutical industrial management experience, both sides will integrate complementary strengths to deliver medical and biopharmaceutical clean spaces compliant with Indonesian national standards, HALAL certification, international ISO 14644 cleanroom specifications and pharmaceutical GMP standards.
Executives from both organizations delivered speeches during the signing event.
The management representative of OCCR stated: Indonesia’s healthcare infrastructure and biopharmaceutical industry maintain steady growth, while local medical institutions and pharmaceutical factories face rising demand for standardized, high-quality cleanroom construction. This strategic partnership with Indonesia’s medical leader stands as a core milestone of our Southeast Asia layout covering medical purification and biopharmaceutical cleanroom sectors. We will deliver complete full-chain cleanroom technology for food, medical and biopharmaceutical industries and rely on our local construction team to provide stable, compliant one-stop purification engineering services for healthcare facilities and pharmaceutical manufacturers nationwide.

The representative of the medical partner commented: Controlled clean environments are the fundamental guarantee of medical safety and compliant pharmaceutical production, and our enterprise is committed to upgrading hardware standards of local Indonesian medical services and standardizing the domestic biopharmaceutical industry. OCCR’s proven track record in medical and biopharmaceutical cleanroom delivery and construction technology adapted to tropical humid climates perfectly aligns with our development goals. We expect to launch multiple benchmark hospital purification projects and biopharmaceutical dust-free workshop projects through this alliance, jointly driving standardized development of Indonesia’s medical and pharmaceutical cleanroom construction industry.
Per the signed agreement, both parties will establish a permanent joint collaboration system to jointly explore medical and biopharmaceutical purification markets in Indonesia and wider Southeast Asia. The alliance will share channel resources, technical solutions and project execution capacity to expand diversified businesses, including new hospital construction, renovation of existing clean zones, clinical laboratory upgrades, and new construction & retrofitting of biopharmaceutical plants, unlocking broader international market opportunities together.

About PT Ocean Purification Indonesia (OCCR)
As the overseas wholly-owned subsidiary of OCEAN Purification, OCCR has operated in Indonesia for years, specializing in turnkey cleanroom projects for food, medical and biopharmaceutical industries. We deliver full-cycle services covering design, partition manufacturing, AHU ventilation installation and long-term maintenance, with multiple landmark cleanroom references in bakery, dairy, private hospital and biopharmaceutical pilot plant sectors across Southeast Asia.
